Ralf Reilmann

11.3k citations

145 papers · 6.2k indexed · 3 hit papers · h-index 36

Impact in

Cellular and Molecular Neuroscience top 0.2%
- Genetic Neurodegenerative Diseases
- Neuroscience and Neuropharmacology Research
Neurology top 0.1%
- Neurological disorders and treatments
- Parkinson's Disease Mechanisms and Treatments
- Botulinum Toxin and Related Neurological Disorders

Papers in

Cellular and Molecular Neuroscience 119
- Genetic Neurodegenerative Diseases 117
Neurology 96
- Neurological disorders and treatments 83
- Parkinson's Disease Mechanisms and Treatments 29
- Botulinum Toxin and Related Neurological Disorders 13

Co-authors: Blair R. Leavitt Sarah J. Tabrizi Julie C. Stout Douglas R. Langbehn Rachael I. Scahill Raymund A.C. Roos G. Bernhard Landwehrmeyer David Craufurd
Journals: Movement Disorders (18 papers)Journal of Huntington s Disease (12 papers)Journal of Neurology Neurosurgery & Psychiatry (11 papers)Neurology (10 papers)The Lancet Neurology (5 papers)
Partner nations: Germany United States United Kingdom

In The Last Decade

Ralf Reilmann

135 papers receiving 6.1k citations

Hit Papers

align trajectories log scale

Huntington disease: natural history, biomarkers and prospects for therapeutics 2014 · 705 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2014 Nature Reviews Neurology
2013 The Lancet Neurology
2009 The Lancet Neurology

Peers

Countries citing papers authored by Ralf Reilmann

Since Specialization

Citations

This map shows the geographic impact of Ralf Reilmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralf Reilmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralf Reilmann more than expected).

Fields of papers citing papers by Ralf Reilmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralf Reilmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralf Reilmann. The network helps show where Ralf Reilmann may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ralf Reilmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ralf Reilmann Line = papers co-authored together Ralf Reilmann links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Digital Outcomes of Upper Limb Ataxia Capture Meaningful Longitudinal Change and Treatment Response Movement Disorders ·杨学伟, Robin Schubert, Hanako Hatakeyama, Winfried Ilg, Rebecca Schüle, Ralf Reilmann, Matthis Synofzik, Andreas Traschütz	2025	0
2	The joint memory effect: challenging the selfish stigma in Huntington’s disease? Brain Communications ·唐光旭, Tsivtsina Nina Viktorovna, Laurent Cléret de Langavant, Katia Youssov, Carlos Fabián Paucar Gutiérrez, Renaud Massart, Robin Schubert, Ralf Reilmann, Charlotte Jacquemot, Blanche Bapst, Monica Busse, David Craufurd, Anne Rosser, Marine Lunven, Anne‐Catherine Bachoud‐Lévi	2024	0
3	Cognitive processes of apathy in Huntington’s disease show high sensitivity to disease progression Clinical Parkinsonism & Related Disorders ·Iraj RaesIi, Anne‐Catherine Bachoud‐Lévi, Ralf Reilmann, David Craufurd, Monica Busse, Anne Rosser, 马毅飞	2022	0
4	Immediate effects of treadmill walking in individuals with Lewy body dementia and Huntington’s disease Gait & Posture ·Deb Kegelmeyer, Sandra K. Kostyk, Nora E. Fritz, Douglas W. Scharre, Gregory Young, Yubo Tan, Robin Schubert, Ralf Reilmann, Anne Kloos	2021	5
5	Huntington Study Group Abstracts 2020 Neurotherapeutics ·Erin M. Edwards, Nora E. Fritz, Huaiyin Chen, Валентина Игоревна Бронер, Cuong Chi Tran, M. Feuerstack, M. H. Schwab, Deb Kegelmeyer, Sandra K. Kostyk, R. Giacosie, Douglas W. Scharre, Gregory R. Young, Yubo Tan, Robin Schubert, Ralf Reilmann, Anne Kloos	2020	0
6	Activity or connectivity? A randomized controlled feasibility study evaluating neurofeedback training in Huntington’s disease Brain Communications ·Marina Papoutsi, Dewi Sahara Nasution, Oliver Josephs, Sophia E. Pépés, Awadhesh Kumar Yada, Ralf Reilmann, Nigel Hunt, 宏遠永井, Nikolaus Weiskopf, Douglas R. Langbehn, Geraint Rees, Sarah J. Tabrizi	2020	9
7	How specific are non-motor symptoms in the prodrome of Parkinson's disease compared to other movement disorders? Parkinsonism & Related Disorders ·Mariana Moscovich, Sebastian Heinzel, Ronald B. Postuma, Ralf Reilmann, Thomas Klockgether, Heike Jacobi, Günter U. Höglinger, Daniela Berg	2020	12
8	Quantitative grip force assessment of muscular weakness in chronic inflammatory demyelinating polyneuropathy BMC Neurology ·Juliane Klehmet, C.M. Perou, Sarah Hoffmann, Austin E. Graham, Friedemann Paul, Ralf Reilmann, Alexander U. Brandt, Andreas Meisel	2019	2
9	A roadmap for implementation of patient‐centered digital outcome measures in Parkinson's disease obtained using mobile health technologies Movement Disorders ·Alberto J. Espay, Jeffrey M. Hausdorff, Álvaro Sánchez‐Ferro, Jochen Klucken, Aristide Merola, Paolo Bonato, Serene S. Paul, Fay B. Horak, Joaquín A. Vizcarra, Tiago Mestre, Ralf Reilmann, Alice Nieuwboer, E. Ray Dorsey, Lynn Rochester, Bastiaan R. Bloem, Walter Maetzler, (unknown)	2019	214
10	Interrater Reliability of the Unified Huntington's Disease Rating Scale‐Total Motor Score Certification Movement Disorders Clinical Practice ·MuhammadYunus, Raymund A.C. Roos, Jean‐Marc Burgunder, Johan Marinus, Ralf Reilmann	2018	14
11	Cross-sectional and longitudinal voxel-based grey matter asymmetries in Huntington's disease NeuroImage Clinical ·Lora Minkova, Sarah Gregory, Rachael I. Scahill, Ahmed Abdulkadir, Christoph P. Kaller, Jessica Peter, Jeffrey D. Long, Julie C. Stout, Ralf Reilmann, Raymund A.C. Roos, Alexandra Dürr, Blair R. Leavitt, Sarah J. Tabrizi, Stefan Klöppel	2017	24
12	A randomized, controlled trial of a multi-modal exercise intervention in Huntington’s disease Parkinsonism & Related Disorders ·Lori Quinn, Ingo Schmidt, Mark Kelson, Helen Dawes, Johnny Collett, Julia Townson, Raymund A.C. Roos, Anton A. van der Plas, Ralf Reilmann, Jan C. Frich, Hugh Rickards, Anne Rosser, Monica Busse	2016	64
13	Digitomotography in Parkinson’s Disease: A Cross-Sectional and Longitudinal Study PLoS ONE ·Walter Maetzler, 武司飯塚, Tanja Heger, Christian Saß, Daniela Berg, Ralf Reilmann	2015	21
14	One-year safety and tolerability profile of pridopidine in patients with Huntington disease Neurology ·Ferdinando Squitieri, G. Bernhard Landwehrmeyer, Ralf Reilmann, Anne Rosser, Justo Garcı́a de Yébenes, G R V Gustavo Rojas Velasco, Luz María, Jeremy R. Bright, Åsa Rembratt	2013	16
15	Pharmacological treatment of chorea in Huntington's disease–good clinical practice versus evidence‐based guideline Movement Disorders ·Ralf Reilmann	2013	43
16	BETTER GLOBAL AND COGNITIVE FUNCTIONING FOR CHOREATIC COMPARED TO HYPOKINETIC-RIGID HUNTINGTON'S DISEASE Journal of Neurology Neurosurgery & Psychiatry ·Andreea Stretea, Ashok Kumar, J‐M. Burgunder, Anna Rita Bentivoglio, David Craufurd, Ralf Reilmann, Carsten Saft, R. A. C. Roos	2012	0
17	Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data The Lancet Neurology ·Sarah J. Tabrizi, Ralf Reilmann, Raymund A.C. Roos, Alexandra Dürr, Blair R. Leavitt, Gail Owen, Rebecca Jones, Hans J. Johnson, David Craufurd, Stephen L. Hicks, Christopher Kennard, G. Bernhard Landwehrmeyer, Julie C. Stout, Beth Borowsky, Rachael I. Scahill, Chris Frost, Douglas R. Langbehn	2011	408
18	What is the impact of education on Huntington's disease? Movement Disorders ·José Luis López-Sendón, Ana Royuela, О. В. Машукова, Michael Orth, Herwig W. Lange, Ralf Reilmann, Dick Ruddell, Hugh Rickards, Silvia Piacentini, Ferdinando Squitieri, G. Bernhard Landwehrmeyer, Marie‐Noëlle W. Witjes‐Ané, Caroline K. Jurgens, Raymund A.C. Roos, Víctor Abraira, Justo Garcı́a de Yébenes, (unknown)	2011	33
19	Grasping premanifest Huntington's disease – shaping new endpoints for new trials Movement Disorders ·Ralf Reilmann, Stefan Bohlen, Thomas Klopstock, Andreas Bender, A. Weindl, Philipp G. Saemann, Dorothee P. Auer, E. Bernd Ringelstein, Herwig W. Lange	2010	35
20	Initiation and development of fingertip forces during whole-hand grasping Experimental Brain Research ·Ralf Reilmann, Andrew M. Gordon, H. Henningsen	2001	48

About Ralf Reilmann

Ralf Reilmann is a scholar working on Cellular and Molecular Neuroscience, Neurology, Neurology, Molecular Biology and Psychiatry and Mental health, having authored 145 papers that have together received 6.2k indexed citations. Recurring topics across this work include Genetic Neurodegenerative Diseases (117 papers), Neurological disorders and treatments (83 papers), Mitochondrial Function and Pathology (39 papers), Parkinson's Disease Mechanisms and Treatments (29 papers), Botulinum Toxin and Related Neurological Disorders (13 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (5 papers), Advanced Neuroimaging Techniques and Applications (5 papers) and Muscle Physiology and Disorders (4 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (4.8k citations), Neurology (3.9k citations), Neurology (362 citations), Molecular Biology (2.6k citations) and Cognitive Neuroscience (629 citations). Ralf Reilmann has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Blair R. Leavitt, Sarah J. Tabrizi, Julie C. Stout, Douglas R. Langbehn, Rachael I. Scahill, Raymund A.C. Roos, G. Bernhard Landwehrmeyer, David Craufurd, Alexandra Dürr and Hans J. Johnson. Their work appears in journals such as Movement Disorders, Journal of Huntington s Disease, Journal of Neurology Neurosurgery & Psychiatry, Neurology and The Lancet Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact